| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Cacace Angela M | Chief Scientific Officer | C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN | /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace | 18 Jun 2025 | 0002026306 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARVN | Common Stock | Sale | $19,347 | -2,583 | -1.6% | $7.49 | 154,248 | 17 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 50% of the reporting person's restricted stock units (RSUs) granted on June 17, 2024. |